[Procainamide- and quinidine-induced immunological changes].
D000974:Antibodies, Antinuclear / Q000032:analysis; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced; D008875:Middle Aged; D011342:Procainamide / Q000009:adverse effects* / Q000627:therapeutic use; D011802:Quinidine / Q000009:adverse effects* / Q000627:therapeutic use
D000974:Antibodies, Antinuclear; D007136:Immunoglobulins; D011802:Quinidine; D011342:Procainamide
Prokaiiniamidin ja kinidiinin aiheuttamat immunologiset muutokset